EFFICACY AND SAFETY OF DUPILUMAB TREATMENT UP TO 1 YEAR IN INFANTS AND PRESCHOOL CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

被引：0
|
作者：
Cork, Michael J. [1 ,2 ]
Paller, Amy S. [3 ,4 ]
Siegfried, Elaine C. [1 ,2 ,5 ,6 ]
Xiao, Jing [7 ]
Prescilla, Randy [8 ]
Dubost-Brama, Ariane [9 ]
Bansal, Ashish [7 ]
机构：
[1] Univ Sheffield, Sheffield Dermatol Res, Sheffield, S Yorkshire, England
[2] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[4] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[5] St Louis Univ, St Louis, MO USA
[6] Cardinal Glennon Childrens Hosp, St Louis, MO USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Cambridge, MA USA
[9] Sanofi, Chilly Mazarin, France
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P10.8
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [41] Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year COMMENT
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Simpson, Eric L.
    Chen, Zhen
    Ardeleanu, Marius
    Rossi, Ana B.
    DERMATOLOGY AND THERAPY, 2022, 12 (01) : 9 - 13
  • [42] SAFETY AND EFFICACY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF UP TO 100 WEEKS (LIBERTY AD OLE)
    Herranz, Pedro
    de la Cueva, Pablo
    Rodriguez Marco, Ainara
    Worrell, Richard
    Shumel, Brad
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 25 - 25
  • [43] SAFETY AND EFFICACY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF UP TO 100 WEEKS (LIBERTY AD OLE)
    Roh, Joo Young
    Park, Chun Wook
    Kim, Kyu Han
    Lee, Joo Hee
    Sun, Xian
    Rossi, Ana B.
    Shumel, Brad
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 53 - 53
  • [44] Maintenance of efficacy and safety with lebrikizumab up to one year of treatment in patients with moderate-to-severe atopic dermatitis with or without topical corticosteroids
    Guttman-Yassky, E.
    Weidinger, S.
    Silverberg, J.
    Gooderham, M.
    Thyssen, J.
    Irvine, A.
    Elmaraghy, H.
    Natalie, C.
    Hu, C.
    Pierce, E.
    Gil, E. G.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S348 - S348
  • [45] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
    Marshall, Claire
    Littlewood, Zoe
    Herety, Nichola
    Heal, Calvin
    Sharif, Jennifer
    Clayton, Tim
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
  • [46] Efficacy and safety of dupilumab with concomitant topical corticosteroids for up to 1 year in moderate-to-severe atopic dermatitis: a randomized, placebo-controlled phase III trial (CHRONOS)
    Blauvelt, A.
    Gooderham, M.
    Foley, P.
    Griffiths, C. E. M.
    Cather, J. C.
    de Bruin-Weller, M.
    Soo, Y.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 10 - 10
  • [47] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [48] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [49] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [50] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
    Tofte, Susan J.
    Papp, Kim
    Sadick, Neil
    Bohnert, Krista
    Simpson, Eric
    Thaci, Diamant
    Bieber, Thomas
    Blauvelt, Andrew
    Sofen, Howard
    Gooderham, Melinda
    Chen, Zhen
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 (09): : 529 - 541
12345